What is the name of the subsidiary that PharmaEssentia plans to establish in Puerto Rico, USA, and what is its ownership structure?

The subsidiary is tentatively named PharmaEssentia Americas LLC and will be a 100% owned subsidiary of PharmaEssentia.

On what date did PharmaEssentia's board of directors pass the resolution to invest in the new subsidiary in Puerto Rico?

PharmaEssentia's board of directors passed the resolution on April 9, 2026, according to the ROC calendar.

What is the total amount of investment that PharmaEssentia has approved for the establishment of its second subsidiary in Puerto Rico?

The total transaction amount approved for the investment in PharmaEssentia Americas LLC is US$34,000,000.

Is the counterparty in this transaction a related party, and if so, what is its relationship to PharmaEssentia?

Yes, the counterparty is PharmaEssentia Americas LLC, which is a 100% owned subsidiary of PharmaEssentia.

Was there any previous transfer or ownership of the subject matter by a related party within the past five years?

No, the subject matter of the transaction has not been owned by any related party of PharmaEssentia within the past five years.

AI News NQ Analysis

PharmaEssentia: Announcement of the Company's Board of Directors' Resolution to Invest and Establish a Second Subsidiary in Puerto Rico, USA

NQ Score 66/100

AI Summary (NQ-processed)

PharmaEssentia's board of directors resolved on April 9, 2026, to establish a second subsidiary, PharmaEssentia Americas LLC (tentative name), in Puerto Rico, USA, with an investment of US$34 million. This is part of the overall operational plan, and the company had previously established PharmaEssentia Puerto Rico LLC, with the total investment for both subsidiaries now adjusted.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the name of the subsidiary that PharmaEssentia plans to establish in Puerto Rico, USA, and what is its ownership structure?: A: The subsidiary is tentatively named PharmaEssentia Americas LLC and will be a 100% owned subsidiary of PharmaEssentia.
Q: On what date did PharmaEssentia's board of directors pass the resolution to invest in the new subsidiary in Puerto Rico?: A: PharmaEssentia's board of directors passed the resolution on April 9, 2026, according to the ROC calendar.
Q: What is the total amount of investment that PharmaEssentia has approved for the establishment of its second subsidiary in Puerto Rico?: A: The total transaction amount approved for the investment in PharmaEssentia Americas LLC is US$34,000,000.
Q: Is the counterparty in this transaction a related party, and if so, what is its relationship to PharmaEssentia?: A: Yes, the counterparty is PharmaEssentia Americas LLC, which is a 100% owned subsidiary of PharmaEssentia.
Q: Was there any previous transfer or ownership of the subject matter by a related party within the past five years?: A: No, the subject matter of the transaction has not been owned by any related party of PharmaEssentia within the past five years.